𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The in vitro receptor profile of rotigotine: a new agent for the treatment of Parkinson’s disease

✍ Scribed by Dieter Scheller; Christoph Ullmer; Reinhard Berkels; Mirella Gwarek; Hermann Lübbert

Book ID
105876842
Publisher
Springer-Verlag
Year
2008
Tongue
English
Weight
393 KB
Volume
379
Category
Article
ISSN
0028-1298

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

New delivery techniques in the drug trea
New delivery techniques in the drug treatment of Parkinson's disease
✍ W. Poewe 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB

A marked response to oral dopaminergic substitution is one of the diagnostic criteria for idiopathic Parkinson's disease. Oral L-Dopa treatment remains to be the most efficacious and best tolerated way of parkinsonian drug therapy. A majority of patients, however, will develop late complications inc

Sertraline for the treatment of depressi
Sertraline for the treatment of depression in parkinson's disease
✍ Dr. Robert A. Hauser; Theresa A. Zesiewicz 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 384 KB 👁 2 views

## Abstract Although antidepressant medications are commonly used to treat depression in Parkinson's disease (PD), little information is available regarding their safety and efficacy in this condition. Sertraline is a relatively selective serotonin reuptake inhibitor with some dopamine reuptake inh